NRX Pharmaceuticals Inc (FRA:B1Q)
€ 4.86 0 (0%) Market Cap: 12.65 Mil Enterprise Value: 18.05 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 30/100

NRX Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) Transcript

Sep 14, 2022 / 01:00PM GMT
Release Date Price: €7.38 (+9.17%)
Sean Lee
H.C. Wainwright & Co., LLC - Equity Research Analyst

Good morning, everyone, and thank you for attending the H.C. Wainwright 24th Annual Global Investment Conference. My name is Sean Lee. I'm an equity research analyst at the bank. To this morning's presentation, I'd like to welcome Mr. Steve Willard, who is the Chief Executive Officer of NRx Pharmaceuticals.

Steve Willard
NRx Pharmaceuticals, Inc. - CEO

Thank you very much, and we're delighted to be here at H.C. Wainwright and have the opportunity to present to people who are interested in what the exciting things that we do are to offer.

We offer -- first of all, a forward-looking statement. We are a public company, and it's important, and I will be making statements about the future that are covered within the Safe Harbor Act as set out in the presentation.

We bring hope to life. That's what we basically do. To try accomplish that is we take existing drugs, which have a demonstrated safety profile, and we find new methods of mechanisms of action or method of application to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot